These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 7892894)

  • 41. Maternal serum thromboxane B2 concentrations do not predict improved outcomes in high-risk pregnancies in a low-dose aspirin trial. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medical Units.
    Hauth J; Sibai B; Caritis S; VanDorsten P; Lindheimer M; Klebanoff M; MacPherson C; Landon M; Paul R; Miodovnik M; Meis P; Dombrowski M; Thurnau G; Walsh S; McNellis D; Roberts JM
    Am J Obstet Gynecol; 1998 Nov; 179(5):1193-9. PubMed ID: 9822499
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.
    Vicari AM; Viganó D'Angelo S; Testa S; Comi G; Galardi G; Orsi E; D'Angelo A
    Horm Metab Res; 1992 Nov; 24(11):516-9. PubMed ID: 1452117
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Coagulation, fibrinolytic and platelet function in patients on long-term therapy with aspirin 300 mg or 1,200 mg daily compared with placebo.
    Hampton KK; Cerletti C; Loizou LA; Bucchi F; Donati MB; Davies JA; de Gaetano G; Prentice CR
    Thromb Haemost; 1990 Aug; 64(1):17-20. PubMed ID: 2073296
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Low-dose aspirin. II. Relationship of angiotensin II pressor responses, circulating eicosanoids, and pregnancy outcome.
    Brown CE; Gant NF; Cox K; Spitz B; Rosenfeld CR; Magness RR
    Am J Obstet Gynecol; 1990 Dec; 163(6 Pt 1):1853-61. PubMed ID: 2256495
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tissue plasminogen activator, plasminogen activator inhibitors, and activator-inhibitor complex in liver disease.
    Leiper K; Croll A; Booth NA; Moore NR; Sinclair T; Bennett B
    J Clin Pathol; 1994 Mar; 47(3):214-7. PubMed ID: 8163691
    [TBL] [Abstract][Full Text] [Related]  

  • 46. t-PA activity in peripheral blood obtained from pregnant women.
    Ishii A; Yamada S; Yamada R; Hamada H
    J Perinat Med; 1994; 22(2):113-7. PubMed ID: 7965540
    [TBL] [Abstract][Full Text] [Related]  

  • 47. 6-Keto prostaglandin F1 alpha, thromboxane B2, and 13,14-dihydro-15-keto prostaglandin F concentrations of normotensive and preeclamptic patients during pregnancy, delivery, and the postpartum period.
    Yamaguchi M; Mori N
    Am J Obstet Gynecol; 1985 Jan; 151(1):121-7. PubMed ID: 3838119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of troglitazone on blood concentrations of plasminogen activator inhibitor 1 in patients with type 2 diabetes and in lean and obese normal subjects.
    Kruszynska YT; Yu JG; Olefsky JM; Sobel BE
    Diabetes; 2000 Apr; 49(4):633-9. PubMed ID: 10871202
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of aspirin on the fibrinolytic response in perfused rat hindquarters.
    Iacoviello L; De Curtis A; Amore C; D'Adamo MC; Buczko W; de Gaetano G; Donati MB
    Eur J Pharmacol; 1992 Dec; 229(1):39-44. PubMed ID: 1473562
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of cyclosporine on regulators of fibrinolysis in plasma from renal allograft recipients.
    Elhasade AS; Perkowska A; Paczek L; Rowiński W; Soluch L; Szmidt J; Gałazka Z; Gaciong Z
    Ann Transplant; 1998; 3(1):13-8. PubMed ID: 9869892
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of angiotensin converting enzyme and angiotensin II receptor inhibition on impaired fibrinolysis in systemic hypertension.
    Erdem Y; Usalan C; Haznedaroğlu IC; Altun B; Arici M; Yasavul U; Turgan C; Cağlar S
    Am J Hypertens; 1999 Nov; 12(11 Pt 1):1071-6. PubMed ID: 10604482
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis.
    Herrick AL; Illingworth K; Blann A; Hay CR; Hollis S; Jayson MI
    Ann Rheum Dis; 1996 Feb; 55(2):122-7. PubMed ID: 8712862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Studies on the mechanism of action of oral contraceptives with regard to fibrinolytic variables.
    Kooistra T; Bosma PJ; Jespersen J; Kluft C
    Am J Obstet Gynecol; 1990 Jul; 163(1 Pt 2):404-13. PubMed ID: 2164773
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Thromboxane A2 and prostacyclin generation in the microvasculature of patients with atherosclerosis--effect of low-dose aspirin.
    Kyrle PA; Minar E; Brenner B; Eichler HG; Heistinger M; Marosi L; Lechner K
    Thromb Haemost; 1989 Jun; 61(3):374-7. PubMed ID: 2508252
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Fibrinolytic response to exercise in women using third-generation oral contraceptives.
    Weiss C; Walter B; Dorsch MF; Bärtsch P
    Blood Coagul Fibrinolysis; 2006 Oct; 17(7):563-8. PubMed ID: 16988552
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Urinary excretion of prostacyclin and thromboxane metabolites in threatened preterm labor: effect of indomethacin and nylidrin.
    Kurki T; Viinikka L; Ylikorkala O
    Am J Obstet Gynecol; 1992 Jan; 166(1 Pt 1):150-4. PubMed ID: 1733190
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Influence of heparin and a low molecular weight heparinoid on specific endogenous and exogenous fibrinolytic factors during rest and exercise.
    de Boer A; Kluft C; Dooijewaard G; Kasper FJ; Kroon JM; Breimer DD; Stiekema JC; Cohen AF
    Thromb Haemost; 1992 Nov; 68(5):550-5. PubMed ID: 1280862
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Low-dose aspirin preventing pregnancy induced hypertension].
    Cheng WW; Zhang ZJ
    Zhonghua Fu Chan Ke Za Zhi; 1991 Nov; 26(6):342-5, 387. PubMed ID: 1804603
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Activation of both coagulation and fibrinolysis in childhood hemolytic uremic syndrome.
    Van Geet C; Proesmans W; Arnout J; Vermylen J; Declerck PJ
    Kidney Int; 1998 Oct; 54(4):1324-30. PubMed ID: 9767551
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Acute effects of defibrotide, an experimental antithrombotic agent, on fibrinolysis and blood prostanoids in man.
    Coccheri S; Biagi G; Legnani C; Bianchini B; Grauso F
    Eur J Clin Pharmacol; 1988; 35(2):151-6. PubMed ID: 3191933
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.